A non-government entity
The Medicare drug price negotiation Program for 2026 is a transformative initiative designed to lower prescription drug costs for millions of Americans. By allowing Medicare to negotiate directly with pharmaceutical companies, this program aims to alleviate financial burdens and improve access to essential medications.
The Medicare prescription drug negotiation program is a vital initiative aimed at reducing prescription medication costs for millions of Americans. By allowing Medicare to negotiate prices directly with pharmaceutical companies, the program seeks to improve affordability and accessibility for beneficiaries.
Through NewMedicare.com we help you to speak with a licensed insurance agent to compare rates from different carriers so that you can make informed decisions about your insurance coverage.
Hours of Operation: 9am – 6pm EST
This is a solicitation for insurance. NewMedicare.com is powered by Astoria Company Marketing, LLC, a non-government entity. Licensed insurance agents are not connected with or endorsed by the U.S. government or the federal Medicare program.
This is an advertisement.
We do not offer every plan available in your area. Currently, we represent [18] organizations that offer [52,101] products in your area. Please contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Program (SHIP)
to get information on all of your options.
Participating sales agencies represent Medicare Advantage HMO, PPO and PFFS organizations and stand-alone PDP prescription drug plans that are contracted with Medicare. Enrollment depends on the plan’s contract renewal. Please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week.
Enrollment in the described plan type may be limited to certain times of the year unless you qualify for a Special Enrollment Period.
Medicare supplement insurance is available to those age 65 or older enrolled in Medicare Parts A and B, and in some states to those under age 65 eligible to Medicare due to disability or end stage renal disease.
Copyright © 2025/2026 Astoria Company Marketing, LLC. All rights reserved.
MMR-2018-2024
MMR-3494
MULTIPLAN_NEWMEDWEB2026_HCI_C
